Search & Analyze

Entero Healthcare Solutions Ltd.

TradingTrading

www.enterohealthcare.com BSE: 544122NSE: ENTERO

₹1,725.60BSE4.03%

16 Sep, 4:01 PM

₹1,725.60

₹7.53K Cr

60.04

4.34

8.57%

₹1,800.00

₹1,666.55

₹1,919.25

₹944.00

Customise metrics bar

Price Performance

Peer Comparison

Name
ADANI ENTER ADANIENT	2,924.10	53.17	3,95,842.03	0.04	-1,461.54	-249.67%	32,923.98	49.92%	13.30
AEGISLOG AEGISLOG	1,381.20	38.75	48,480.12	0.63	544.84	210.70%	2,356.86	37.07%	19.76
CPPLUS CPPLUS	3,555.00	87.91	42,055.80	0.05	142.20	332.51%	1,402.42	89.51%	29.48
PREMIERENE PREMIERENE	899.00	24.51	40,810.24	0.11	471.92	53.32%	2,462.59	35.25%	33.72
REDINGTON REDINGTON	387.35	17.84	30,282.03	1.55	453.49	94.65%	34,922.47	34.57%	18.96
HONASA HONASA	471.35	61.40	15,367.15	0.64	90.45	118.87%	755.95	27.00%	20.87
LLOYDSENT LLOYDSENT	66.70	91.03	10,182.10	0.22	109.98	-55.77%	563.03	70.15%	12.84
Entero Healthcare Solutions Ltd. ENTERO	1,725.60	60.04	7,529.49	0.00	52.05	72.17%	1,940.50	38.23%	10.93

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,034.18	1,097.04	1,300.69	1,359.00	1,339.06	1,403.82	1,570.95	1,706.52	1,909.93	1,940.50
Expenses	1,005.30	1,066.86	1,258.24	1,308.98	1,290.14	1,353.75	1,508.88	1,638.74	1,823.89	1,843.50
	28.88	30.17	42.45	50.01	48.91	50.07	62.07	67.77	86.04	96.99
	2.79%	2.75%	3.26%	3.68%	3.65%	3.57%	3.95%	3.97%	4.50%	5.00%
	9.15	13.44	11.28	7.50	7.29	5.83	4.79	-3.57	4.01	3.01
Interest	17.32	9.70	11.46	9.97	10.49	10.66	12.40	14.01	17.31	20.57
	7.14	6.61	7.49	8.10	8.49	8.87	9.83	9.80	14.79	12.31
	13.56	27.30	34.78	39.44	37.23	36.36	44.63	40.40	57.95	67.12
	-56.17%	24.80%	25.14%	25.33%	15.59%	16.86%	17.98%	16.14%	22.12%	22.45%
	20.97	20.08	23.62	25.44	25.69	27.80	31.60	27.63	28.01	38.16
	4.82	4.62	5.43	5.85	5.90	6.39	7.26	6.35	6.44	8.77

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	2,522.07	3,300.21	3,922.31	5,095.78	6,591.21
	2,522.07	3,300.21	3,922.31	5,095.78	6,591.21
EXPENDITURE :
Increase/Decrease in Stock	-30.03	-19.40	-57.46	-147.01	-4.01
Raw Material Consumed	2,342.47	3,051.26	3,627.81	4,756.49	5,914.84
Power & Fuel Cost	4.07	4.25	5.60	7.20	8.54
Employee Cost	114.81	128.14	151.15	199.04	245.50
Other Manufacturing Expenses	1.22	1.26	1.29	1.38	3.27
General and Administration Expenses	28.85	30.08	34.36	39.47	56.98
Selling and Distribution Expenses	26.01	29.68	36.28	52.39	74.97
Miscellaneous Expenses	10.23	10.93	11.44	15.27	25.18
	2,497.63	3,236.20	3,810.47	4,924.23	6,325.26
Operating Profit (Excl OI)	24.44	64.01	111.84	171.55	265.95
	4.48	5.51	14.41	39.51	19.24
	28.92	69.52	126.26	211.05	285.19
Interest	28.98	48.97	65.68	41.62	54.39
PBDT	-0.06	20.55	60.57	169.43	230.81
	19.75	24.24	25.02	30.69	43.29
Profit Before Taxation & Exceptional Items	-19.81	-3.69	35.56	138.74	187.51
Exceptional Income / Expenses					-8.18
	-19.81	-3.69	35.56	138.74	179.34
Provision for Tax	9.63	7.42	-4.24	31.31	33.50
	-29.44	-11.10	39.80	107.43	145.84
Extra items				0.00	0.00
Minority Interest	-0.48	-0.45	-0.69	-12.61	-30.80
Consolidated Net Profit	-29.92	-11.56	39.11	94.82	115.04
Profit Balance B/F	-31.85	-61.80	-72.70	-33.81	63.83
Appropriations	-61.77	-73.36	-33.59	61.01	178.87
	-77.71	-28.11	8.99	21.79	26.44
Adjusted EPS	-77.71	-28.11	8.99	21.79	26.44

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	622.84	667.73	43.49	43.51	43.51
Share Warrants & Outstandings			1.77	4.24	6.42
Total Reserves	-61.80	-72.70	1,592.79	1,676.40	1,638.68
Reserve excluding Revaluation Reserve	-61.80	-72.70	1,592.79	1,676.40	1,638.68
Revaluation reserve	0.00		0.00	0.00
	561.04	595.03	1,638.06	1,724.15	1,688.61
Minority Interest	2.18	2.63	3.33	46.21	63.94
Long-Term Borrowings	37.13
Secured Loans	37.13	31.07	45.54		99.76
Unsecured Loans					22.80
Deferred Tax Assets / Liabilities	1.07	-1.34	-19.00	-14.30	-53.99
Other Long Term Liabilities	57.69	49.97	48.97	77.50	115.95
Long Term Provisions	4.43	5.40	7.11	9.64	21.60
Total Non-Current Liabilities	100.31	85.10	82.62	72.84	206.12
Trade Payables	139.78	210.50	229.92	397.30	725.33
Other Current Liabilities	64.91	67.11	135.04	137.88	397.44
Short Term Borrowings	247.90	342.45	230.01	298.81	444.12
Short Term Provisions	9.19	3.90	6.98	11.02	20.68
Total Current Liabilities	461.78	623.96	601.95	845.02	1,587.57
Total Liabilities	1,125.31	1,306.72	2,325.95	2,688.21	3,546.24
Gross Block	311.22	338.72	383.27	686.47	1,129.14
Less: Accumulated Depreciation	49.25	70.99	93.93	127.19	171.11
Net Block	261.97	267.73	289.34	559.29	958.03
Capital Work in Progress	0.59
Long Term Investment	0.00		0.00	0.00
Long Term Loans & Advances	11.82	14.42	20.20	47.16	72.38
Other Non Current Assets	0.00	1.40	5.44	5.80	4.94
Total Non-Current Assets	274.42	283.55	314.97	612.51	1,037.80
Currents Investments				57.56	129.89
Inventories	310.16	341.63	421.16	659.78	841.68
Sundry Debtors	374.60	514.88	615.40	830.36	1,212.44
Cash and Bank	105.40	106.84	893.18	260.42	161.79
Other Current Assets	24.35	23.17	40.52	66.29	89.06
Short Term Loans and Advances	36.38	36.65	40.71	201.31	68.28
Total Current Assets	850.88	1,023.17	2,010.98	2,075.71	2,503.13
Net Current Assets (Including Current Investments)	389.10	399.21	1,409.03	1,230.69	915.56
Total Assets	1,125.31	1,306.72	2,325.95	2,688.21	3,546.24
Contingent Liabilities	0.01	0.30	0.35	4.01	5.51
Total Debt	285.03	374.32	275.55	298.81	566.68
	-150.52	-166.80	376.21	395.31	386.61
Adjusted Book Value	-150.52	-166.80	376.21	395.31	386.61

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-19.81	-3.69	35.56	138.74	179.34
Adjustment	41.52	71.16	86.62	44.05	107.09
Changes In working Capital	-46.07	-100.36	-145.73	-221.52	-136.48
Cash Flow after changes in Working Capital	-24.36	-32.89	-23.55	-38.73	149.95
Cash Flow from Operating Activities	-35.27	-45.32	-36.61	-76.87	96.20
Cash Flow from Investing Activities	-161.73	-48.60	-705.12	219.80	-303.06
Cash Flow from Financing Activitie	211.19	72.76	862.94	-73.66	123.66
Net Cash Inflow / Outflow	14.19	-21.15	121.21	69.27	-83.20
Opening Cash & Cash Equivalents	32.31	46.51	25.36	147.65	229.28
Cash & Cash Equivalent on Amalgamation / Take over / Merger			1.08	12.36	0.80
Closing Cash & Cash Equivalent	46.51	25.36	147.65	229.28	146.88

Ratios

Valuation

60.04

4.34

24.10

1.06

28.81

398.56

Profitability

8.57

10.93

4.68

4.04

2.21

Leverage & Liquidity

0.34

1.58

4.30

Returns

0.00

2.11

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	52.44	52.44	52.44	52.42	52.42	52.42	52.42	52.42	52.40
	25.38	31.55	30.98	29.56	27.38	24.32	21.56	20.66	19.85
	22.18	16.01	16.59	18.02	20.19	23.26	26.02	26.93	27.75
	47.56	47.56	47.56	47.58	47.58	47.58	47.58	47.58	47.60
No. of Shareholders	66,400	36,767	33,172	33,159	33,338	36,334	40,333	39,084	39,709

Corporate Actions

Showing: All

Date	Type	Details
2026-07-28	AGM
2026-07-28	Board Meeting	Quarterly Results
2026-05-18	Board Meeting	Audited Results & Employees Stock Option Plan

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

TradingTrading

Entero Healthcare Solutions Ltd. operates in the Trading sector under the Trading industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Sanu Kapoor

Vice President- Group General Counsel, Company Secretary & Compliance Officer

—

Sujesh Vasudevan

Chairman

₹23.25 L

Mar '26

Prabhat Agrawal

Managing Director & Chief Executive Officer

₹4.73 Cr

Mar '26

Prem Sethi

Whole Time Director & Chief Operating Officer

₹2.58 Cr

Mar '26

Rajesh Shashikant Dalal

Non Executive Independent Director

₹12.28 L

Mar '25

Sandhya Sharma

Non Executive Independent Director

₹18.75 L

Mar '26

Arun Sadhanandham

Nominee Director

—

Sumona Chakraborty

Nominee Director

—

ENTERO Latest News

News

3 of 3 articles

EQUITY28 Jul 2026 · 16:48

Entero Healthcare Solutions submits board meeting intimation

COMPANY26 May 2026 · 11:28

Entero Healthcare Solutions gets nod to acquire Vishal Surgicals, Vishal Surgicals & Medicals

The Board of Directors of the Company, at its meeting held on May 25, 2026, inter alia, considered and approved the same

EQUITY25 May 2026 · 21:00

Entero Healthcare reports Profit after tax of Rs 134.16 Mln, in the March 2026 quarter

ENTERO

₹1,725.60

-4.03%